Recruitment of Leukemia with Combined Granulocyte-Macrophage and Host Stimulatory Factors

Clinical trials in hematopoietic malignancies at the Johns Hopkins Oncology Center are based on host induced biomodulation which determines the intervals of intensive timed chemotherapy. The aim is to define principles for the use of exogenous cytokines combined with those biologic activities in the intact host.